...
首页> 外文期刊>Stem cell research >An iPSC line (TYWHSTi002-A) derived from a patient with Pendred syndrome caused by compound heterozygous mutations in the SLC26A4 gene
【24h】

An iPSC line (TYWHSTi002-A) derived from a patient with Pendred syndrome caused by compound heterozygous mutations in the SLC26A4 gene

机译:从SLC26A4基因中的化合物杂合突变引起的具有PENDRED综合征的患者的IPSC线(TYWHSTI002-A)

获取原文
           

摘要

Pendred syndrome (PDS) is hereditary and is characterized by thyroid enlargement, cochlea abnormalities, and hearing impairment. In this study, we established an induced pluripotent stem cell line from a PDS patient with familial thyroid disorder, caused by compound heterozygous mutations in SLC26A4 (NM_000441.1; c.919-2AG and c.1614?+?1GA). Isolated peripheral blood mononuclear cells of the patient were reprogrammed using the transgene free Sendai viral vectors, encoding SOX2, OCT4, KLF4, and cMYC. The resulting iPSC line was verified based on morphology, pluripotency markers, and differentiation potential into all three germ layers, and demonstrated typical features in accordance with those of embryo stem cells.
机译:PENDRED综合征(PDS)是遗传性的,其特征在于甲状腺增大,耳蜗异常和听力障碍。在这项研究中,我们通过SLC26A4(NM_000441.1; C.919-2A> G和C.919-2A> G和C.1614)中的复合杂合突变引起了来自具有家族性甲状腺疾病的PDS患者的诱导多能干细胞系。 )。患者的分离外周血单核细胞使用转基因自由仙台病毒载体重新编程,编码SOX2,OCT4,KLF4和CMYC。将得到的IPSC线基于形态学,多能性标记物和分化势验证到所有三种胚层中,并根据胚胎干细胞的那些证明了典型特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号